RANKL-independent osteoclastogenesis in Paget's disease

RANKL-independent osteoclastogenesis in Paget's disease

Dades bibliogràfiques
Autors principals:	Jones, F, Knowles, H, Wass, J, Athanasou, N
Format:	Journal article
Publicat:	2008

Ítems similars

Osteoclast differentiation in Paget's disease is hypersensitive to RANKL.
per: Neale, S, et al.
Publicat: (2000)

Ewing sarcoma cells express RANKL and support osteoclastogenesis
per: Taylor, R, et al.
Publicat: (2011)

Ewing sarcoma cells express RANKL and support osteoclastogenesis.
per: Taylor, R, et al.
Publicat: (2011)

Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL.
per: Neale, S, et al.
Publicat: (2000)

Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.
per: Sun, S, et al.
Publicat: (2006)

RANKL-independent osteoclastogenesis in the SH3BP2 cherubism mice
per: Mizuho Kittaka, et al.
Publicat: (2020-06-01)

RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II.
per: Hemingway, F, et al.
Publicat: (2011)

RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II.
per: Hemingway, F, et al.
Publicat: (2011)

RANKL-Expressing Ectopic Extramammary Paget’s Disease on the Lower Abdomen
per: Akiko Hagiwara-Takita, et al.
Publicat: (2016-06-01)

Investigation of osteoclastogenic signalling of the RANKL substitute LIGHT
per: Hemingway, F, et al.
Publicat: (2013)

Investigation of osteoclastogenic signalling of the RANKL substitute LIGHT.
per: Hemingway, F, et al.
Publicat: (2013)

RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer.
per: Lau, Y, et al.
Publicat: (2007)

Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL
per: Jiarui Li, et al.
Publicat: (2022-11-01)

Parkin Inhibits RANKL-Induced Osteoclastogenesis and Ovariectomy-Induced Bone Loss
per: Weiduo Hou, et al.
Publicat: (2022-10-01)

Niclosamide and its derivative DK‐520 inhibit RANKL‐induced osteoclastogenesis
per: Yurui Jiao, et al.
Publicat: (2020-08-01)

Infection of RANKL-primed RAW-D macrophages with Porphyromonas gingivalis promotes osteoclastogenesis in a TNF-α-independent manner.
per: Akiko Kukita, et al.
Publicat: (2012-01-01)

Involvement of RANKL-dependent/independent mechanisms in osteoclast formation in aseptic loosening
per: Sabokbar, A, et al.
Publicat: (2001)

The Notch1 signaling pathway directly modulates the human RANKL-induced osteoclastogenesis
per: Costanzo Padovano, et al.
Publicat: (2023-12-01)

The Effect of Alendronate on Osteoclastogenesis in Different Combinations of M-CSF and RANKL Growth Factors
per: Věra Hedvičáková, et al.
Publicat: (2021-03-01)

Specnuezhenide suppresses diabetes-induced bone loss by inhibiting RANKL-induced osteoclastogenesis
per: Ye Xiaoshuang, et al.
Publicat: (2022-08-01)

Angiopoietin-like 4 promotes osteosarcoma cell proliferation and migration and stimulates osteoclastogenesis
per: Zhang, T, et al.
Publicat: (2018)

Direct identification of osteoblast progenitor cells in Paget's disease
per: Joyner, C, et al.
Publicat: (1999)

Rankl-independent induction of human osteoclast formation and bone resorption by TGF-beta
per: Itonaga, I, et al.
Publicat: (2002)

Oligomeric proanthocyanidins ameliorates osteoclastogenesis through reducing OPG/RANKL ratio in chicken's embryos
per: Gengsheng Yu, et al.
Publicat: (2024-06-01)

Chemotherapy-induced adipocyte senescence triggers bone loss through RANKL-mediated osteoclastogenesis
per: Ganesh Kumar Raut, et al.
Publicat: (2024-04-01)

α-Linolenic Acid Inhibits RANKL-Induced Osteoclastogenesis In Vitro and Prevents Inflammation In Vivo
per: Yufeng Deng, et al.
Publicat: (2023-02-01)

Giant-cell-rich pseudotumour in Paget's disease.
per: Gamage, N, et al.
Publicat: (2013)

Osteoclast-derived IGF1 induces RANKL production in osteocytes and contributes to pagetic lesion formation
per: Kazuaki Miyagawa, et al.
Publicat: (2023-07-01)

IL-6 induces human osteoclast formation and bone resorption independent of RANK/RANKL interaction
per: Kudo, O, et al.
Publicat: (2001)

The SIRT5-JIP4 interaction promotes osteoclastogenesis by modulating RANKL-induced signaling transduction
per: Kecheng Zhu, et al.
Publicat: (2025-01-01)

Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis
per: Chang-hong Li, et al.
Publicat: (2021-12-01)

Berbamine inhibits RANKL- and M-CSF-mediated osteoclastogenesis and alleviates ovariectomy-induced bone loss
per: Guobin Qi, et al.
Publicat: (2022-11-01)

The mammalian lectin galectin-8 induces RANKL expression, osteoclastogenesis, and bone mass reduction in mice
per: Yaron Vinik, et al.
Publicat: (2015-05-01)

IL-6 Enhances Osteocyte-Mediated Osteoclastogenesis by Promoting JAK2 and RANKL Activity In Vitro
per: Qing Wu, et al.
Publicat: (2017-03-01)

The influence of serum cytokines and growth factors on osteoclast formation in Paget's disease.
per: Neale, S, et al.
Publicat: (2002)

Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism.
per: Kudo, O, et al.
Publicat: (2003)

Corrigendum: Nitazoxanide, an antiprotozoal drug, reduces bone loss in ovariectomized mice by inhibition of RANKL-induced osteoclastogenesis
per: Chang-hong Li, et al.
Publicat: (2023-07-01)

A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro.
per: Kohei Murakami, et al.
Publicat: (2017-01-01)

The Molecular Mechanisms Study of Engeletin Suppresses RANKL-Induced Osteoclastogenesis and Inhibits Ovariectomized Murine Model Bone Loss
per: Feng M, et al.
Publicat: (2023-05-01)

Heterotopic bone formation following hip arthroplasty in Paget's disease.
per: Ferguson, D, et al.
Publicat: (2004)